Mass Vaccine and Drug Administration, Bangladesh

Recruiting now · Phase 4

Conditions studied: Plasmodium Falciparum Malaria

In brief

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass vaccinations, combined mass vaccinations and drug administrations versus the current standard of care.

Key facts

Study ID

NCT06068530

Run by

University of Oxford

People needed

10000

Starts

2025-02-15

Expected to finish

2028-02-01

Last updated by the study team

2025-12-18

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current residence in a study village irrespective of permanence
• Age 6 months and above (no upper age limit)
• Written informed consent provided by participants (or a parent/guardian in case the participant is under 18 years old)

You may not qualify if…

• Pregnancy, plan to get pregnant, or breastfeeding.
• Acute illness requiring intervention
• A history of an adverse reaction to study drugs/vaccine and prior receipt of any other malaria vaccine or enrolment in another intervention trial.

Where it is running

• Alikadam Upazila Health Complex — Bāndarban, Bangladesh (enrolling)
• Lama Upazila Health Complex — Lāma, Bangladesh (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.